Global Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market size was valued at US$ 12 million in 2024 and is forecast to a readjusted size of USD 18.9 million by 2031 with a CAGR of 6.7% during review period.

Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit is an experimental tool used to measure the concentration of Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) protein in a sample.

TIMP-1 is an important protein that regulates the activity of metalloproteases in vivo, and thus participates in the regulation of key biological processes such as extracellular matrix degradation and remodeling, cell migration, and cell proliferation. By using the TIMP-1 ELISA kit, specific antibodies can be used to capture the TIMP-1 protein in the sample, and then its concentration can be accurately determined by detecting the color change. The application of this kit helps in-depth study of the function and regulation mechanism of TIMP-1 in biological processes such as extracellular matrix metabolism, tumor progression, and inflammatory response, and provides an important tool for biomedical research and clinical diagnosis.

This report is a detailed and comprehensive analysis for global Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Elabscience Biotechnology Inc., Shanghai Korain Biotech Co., Ltd., MyBiosource, Inc., Bio-Techne, Abcam, Enzo Life Sciences, Inc., Biomatik, CLOUD-CLONE CORP., Abbexa, Thermo Fisher Scientific (China) Co., Ltd., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Human

Mouse

Rat

Others

Market segment by Application

Hospital

Research Institute

Others

Major players covered

Elabscience Biotechnology Inc.

Shanghai Korain Biotech Co., Ltd.

MyBiosource, Inc.

Bio-Techne

Abcam

Enzo Life Sciences, Inc.

Biomatik

CLOUD-CLONE CORP.

Abbexa

Thermo Fisher Scientific (China) Co., Ltd.

RayBiotech, Inc.

Assay Genie

Wuhan Fine Biotech Co., Ltd.

Geno Technology, Inc.

Arigo Biolaboratories Corp.

Innovative Research

ZodelBiotec Ltd.

ZellBio GmbH

Biorbyt

Creative Diagnostics

Boster Biological Technology

CUSABIO

Sino Biological, Inc.

BioVendor R&D

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit, with price, sales quantity, revenue, and global market share of Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit from 2020 to 2025.

Chapter 3, the Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit.

Chapter 14 and 15, to describe Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) ELISA Kit sales channel, distributors, customers, research findings and conclusion.